| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.33B | 41.37B | 41.23B | 51.03B | 38.96B | 35.44B |
| Gross Profit | 6.52B | 6.21B | 4.73B | 9.45B | 6.73B | 6.77B |
| EBITDA | 2.27B | 2.01B | 502.00M | 4.46B | 2.51B | 2.43B |
| Net Income | 557.00M | 350.00M | -630.00M | 2.17B | 1.02B | 829.00M |
Balance Sheet | ||||||
| Total Assets | 47.33B | 50.09B | 48.65B | 49.39B | 43.07B | 40.53B |
| Cash, Cash Equivalents and Short-Term Investments | 2.32B | 2.10B | 2.33B | 1.90B | 2.00B | 2.81B |
| Total Debt | 12.92B | 14.85B | 12.40B | 10.12B | 7.21B | 7.31B |
| Total Liabilities | 23.54B | 26.23B | 25.09B | 24.56B | 20.05B | 18.23B |
| Stockholders Equity | 23.74B | 23.82B | 23.50B | 24.78B | 22.97B | 22.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.76B | -944.00M | -2.44B | -896.00M | 630.00M |
| Operating Cash Flow | 0.00 | 152.00M | 1.52B | -1.21B | 341.00M | 2.65B |
| Investing Cash Flow | 0.00 | -2.48B | -2.21B | -1.24B | -529.00M | -1.94B |
| Financing Cash Flow | 0.00 | 2.11B | 1.12B | 2.35B | -624.00M | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥46.19B | 11.06 | ― | 2.86% | 4.66% | 19.39% | |
80 Outperform | ¥26.11B | 10.43 | ― | 3.82% | 8.02% | 42.17% | |
69 Neutral | ¥17.87B | 13.15 | ― | 2.41% | 4.00% | 32.05% | |
69 Neutral | ¥85.88B | 20.16 | ― | 2.35% | 6.95% | 8.85% | |
69 Neutral | ¥9.03B | -11.02 | ― | 2.30% | 4.02% | -42.44% | |
64 Neutral | ¥91.82B | 20.17 | ― | 3.41% | 5.84% | -67.78% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |